Kaye Jack

Keryx Biopharmaceuticals Inc.

Director

Avg. Two Year Performance

520% Avg. Purchase Return 149% Compound

43% Avg. Sale Return 19% Compound

Holdings: 85.0K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions